(0.04%) 5 101.83 points
(0.21%) 38 321 points
(0.05%) 15 936 points
(-1.31%) $82.75
(6.24%) $2.04
(0.07%) $2 348.90
(-0.19%) $27.48
(3.82%) $957.35
(-0.20%) $0.933
(-0.30%) $10.99
(-0.54%) $0.796
(1.67%) $93.41
Live Chart Being Loaded With Signals
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples...
Stats | |
---|---|
Šios dienos apimtis | 33.91M |
Vidutinė apimtis | 2.27M |
Rinkos kapitalizacija | 396.23M |
EPS | $0 ( 2024-03-26 ) |
Kita pelno data | ( $0 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.04 |
ATR14 | $0.167 (7.95%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-05 | Taich Adam | Sell | 48 425 | Common Stock |
2024-01-05 | Taich Adam | Sell | 185 812 | Stock Option (Right to buy) |
2024-01-05 | Taich Adam | Sell | 110 000 | Stock Option (Right to buy) |
2024-01-05 | Taich Adam | Sell | 145 000 | Stock Option (Right to buy) |
2024-01-05 | Taich Adam | Sell | 150 000 | Stock Option (Right to buy) |
INSIDER POWER |
---|
-85.54 |
Last 95 transactions |
Buy: 2 347 082 | Sell: 20 640 281 |
Tūris Koreliacija
SomaLogic, Inc. Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
ASTE | 0.801 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
BNIXU | -0.843 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
SomaLogic, Inc. Koreliacija - Valiuta/Žaliavos
SomaLogic, Inc. Finansinės ataskaitos
Annual | 2022 |
Pajamos: | $97.67M |
Bruto pelnas: | $54.30M (55.60 %) |
EPS: | $-0.590 |
FY | 2022 |
Pajamos: | $97.67M |
Bruto pelnas: | $54.30M (55.60 %) |
EPS: | $-0.590 |
FY | 2021 |
Pajamos: | $81.63M |
Bruto pelnas: | $16.06M (19.68 %) |
EPS: | $-0.00100 |
Financial Reports:
No articles found.
SomaLogic, Inc.
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development. Its SomaScan's biomarker discoveries help in diagnostic applications in various areas of diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal research use only and laboratory-developed tests. It serves research and clinical customers with a focus on pharmaceutical and biotechnology companies, and academic research institutions, as well as facilitates drug development, analysis of clinical trials, and new human biology insights by assessing protein-protein and protein-gene networks. The company was incorporated in 1999 and is headquartered in Boulder, Colorado.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.